A Preliminary Study of Sublingual Fentanyl for the Management of Breakthrough Pain Analgesia in Patients With Advanced Cancer
Active, no longer recruiting
Phase of Trial: Phase II
Latest Information Update: 05 Apr 2018
At a glance
- Drugs Fentanyl (Primary)
- Indications Cancer pain
- Focus Therapeutic Use
- 29 Mar 2018 Planned End Date changed from 1 Feb 2019 to 1 Feb 2021.
- 29 Mar 2018 Planned primary completion date changed from 1 Feb 2019 to 1 Feb 2020.
- 29 Mar 2017 Status changed from recruiting to active, no longer recruiting.